Cadaver collagen, derived from deceased donors, is making waves in the beauty industry, particularly in South Korea and Southeast Asia. Marketed as a regenerative skin treatment, it promises to enhance skin elasticity and reduce fine lines by rebuilding the skin’s extracellular matrix. However, the implications of using human-derived materials raise significant ethical and safety concerns.
In the UK, cadaver collagen injections are illegal due to strict regulations surrounding human-derived products. The Medicines and Healthcare products Regulatory Agency (MHRA) has not approved such treatments, primarily due to the risks associated with sourcing and processing human tissue. This includes potential contamination and immune reactions, which could arise if donor screening fails.
While initial studies suggest positive outcomes, such as improved skin density and hydration, the long-term effects and safety of cadaver collagen remain uncertain. The beauty industry is known for its trend-driven nature, but the acceptance of such a controversial treatment may face public resistance due to its origins.
As the demand for innovative beauty solutions grows, the emergence of cadaver collagen highlights a broader trend towards unconventional materials in cosmetic procedures. This could lead to increased scrutiny of safety standards and ethical practices in the beauty sector, particularly as consumers become more aware of what they are injecting into their bodies.
Source: Metro
